Role of Staphylococcus aureus virulence factors in inducing inflammation and vascular permeability in a mouse model of bacterial endophthalmitis

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Kumar, Ajay ^a   Kumar, Ashok ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; STAPHYLOCOCCUS PROTEIN A; TOXIC SHOCK SYNDROME TOXIN 1; VIRULENCE FACTOR; EYE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ELECTRORETINOGRAM; ENDOPHTHALMITIS; FEMALE; HISTOLOGY; INNATE IMMUNITY; MOLECULAR PATHOLOGY; MOUSE; MOUSE MODEL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; RETINA INJURY; STAPHYLOCOCCUS AUREUS; TISSUE INJURY; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; EYE FUNDUS; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ANIMALS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; EYE PROTEINS; FEMALE; FUNDUS OCULI; INFLAMMATION; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PEPTIDOGLYCAN; RETINA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84936863174     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128423     Document Type: Article

References (59)

1. Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013; 19(3):227-34. Epub 2013/02/27. doi: 10.1111/1469-0691.12118 PMID: 23438028; PubMed Central PMCID: PMC3638360.
2. Callegan MC, Gilmore MS, Gregory M, Ramadan RT, Wiskur BJ, Moyer AL, et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res. 2007; 26(2):189-203. Epub 2007/01/24. S1350-9462(06)00069-3 [pii] doi: 10.1016/j.preteyeres.2006.12.001 PMID: 17236804; PubMed Central PMCID: PMC1941835.
3. Callegan MC, Guess S, Wheatley NR, Woods DC, Griffin G, Wiskur BJ, et al. Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis. Retina. 2011; 31(8):1518-24. Epub 2011/05/25. doi: 10.1097/IAE.0b013e318206d176 PMID: 21606892.
4. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006; 31(11):955-65. Epub 2006/11/23. X486J08937426P85 [pii] doi: 10.1080/02713680600976925 PMID: 17114121.
5. Kumar A, Singh CN, Glybina IV, Mahmoud TH, Yu FS. Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J Infect Dis. 2010; 201(2):255-63. Epub 2009/12/10. doi: 10.1086/649589 PMID: 19995266; PubMed Central PMCID: PMC2798006.
6. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS. Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997; 65(4):1550-6. Epub 1997/04/01. PMID: 9119503; PubMed Central PMCID: PMC175169.
7. Sugi N, Whiston EA, Ksander BR, Gregory MS. Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance. Infect Immun. 2013; 81(6):2217-25. Epub 2013/04/10. doi: doi: 10.1128/IAI.00405-12 IAI.00405-12 [pii]. PMID: 23569113; PubMed Central PMCID: PMC3676017.
8. Callegan M, Gilmore M, Gregory M, Ramadan R, Wiskur B, Moyer A, et al. Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions. Prog Retin Eye Res. 2007; 26:189-203. doi: 10.1016/j.preteyeres.2006.12.001 PMID: 17236804
9. Major JC Jr, Engelbert M, Flynn HW Jr, Miller D, Smiddy WE, Davis JL. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010; 149(2):278-83 e1. Epub 2009/11/21. S0002-9394(09)00626-6 [pii] doi: 10.1016/j.ajo.2009.08.023 PMID: 19926069.
10. Gregory M, Callegan MC, Gilmore MS. Role of bacterial and host factors in infectious endophthalmitis. Chem Immunol Allergy. 2007; 92:266-75. Epub 2007/02/01. doi: 10.1159/000099277 [pii]. PMID: 17264502.
11. Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003; 20(5):246-52. Epub 2004/02/18. doi: 307 [pii]. PMID: 14964344.
12. Jackson JJ, Kropp H. beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis. 1992; 165(6):1033-41. Epub 1992/06/01. PMID: 1583320.
13. van Langevelde P, Kwappenberg KM, Groeneveld PH, Mattie H, van Dissel JT. Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS. Antimicrob Agents Chemother. 1998; 42(4):739-43. Epub 1998/04/29. PMID: 9559775; PubMed Central PMCID: PMC105534.
14. Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999; 67(7):3348-56. Epub 1999/06/22. PMID: 10377112; PubMed Central PMCID: PMC116517.
15. Fox A, Hammer ME, Lill P, Burch TG, Burrish G. Experimental uveitis. Elicited by peptidoglycanpolysaccharide complexes, lipopolysaccharide, and muramyl dipeptide. Arch Ophthalmol. 1984; 102(7):1063-7. Epub 1984/07/01. PMID: 6378157.
16. Pandey RK, Yu FS, Kumar A. Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases. Indian J Med Res. 2013; 138(5):609-19. Epub 2014/01/18. doi: IndianJ-MedRes-2013-138-5-609-124632 [pii]. PMID: 24434316; PubMed Central PMCID: PMC3928694.
17. Kumar A, Pandey RK, Miller LJ, Singh PK, Kanwar M. Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis. Crit Rev Immunol. 2013; 33(2):119-35. Epub 2013/04/16. doi: 384cd997794a6ddc,6401b8b11a7124d1 [pii]. PMID: 23582059; PubMed Central PMCID: PMC3697845.
18. Kochan T, Singla A, Tosi J, Kumar A. Toll-Like Receptor 2 Ligand Pretreatment Attenuates Retinal Microglial Inflammatory Response but Enhances Phagocytic Activity toward Staphylococcus aureus. Infect Immun. 2012; 80(6):2076-88. Epub 2012/03/21. IAI.00149-12 [pii] doi: 10.1128/IAI.00149-12 PMID: 22431652.
19. Booth MC, Hatter KL, Miller D, Davis J, Kowalski R, Parke DW, et al. Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun. 1998; 66(1):356-60. Epub 1998/01/10. PMID: 9423880; PubMed Central PMCID: PMC107899.
20. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol. 1988; 170(9):4365-72. Epub 1988/09/01. PMID: 2457579; PubMed Central PMCID: PMC211451.
21. Kumar A, Shamsuddin N. Retinal Muller glia initiate innate response to infectious stimuli via toll-like receptor signaling. PLoS One. 2012; 7(1):e29830. Epub 2012/01/19. doi: doi: 10.1371/journal.pone.0029830 PONE-D-11-22080 [pii]. PMID: 22253793; PubMed Central PMCID: PMC3253788.
22. Bai Y, Shi Z, Zhuo Y, Liu J, Malakhov A, Ko E, et al. In glaucoma the upregulated truncated TrkC.T1 receptor isoform in glia causes increased TNF-alpha production, leading to retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2010; 51(12):6639-51. Epub 2010/06/25. iovs.10-5431 [pii] doi: 10.1167/iovs.10-5431 PMID: 20574020.
23. Talreja D, Kaye KS, Yu FS, Walia SK, Kumar A. Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2014; 55(4):2392-402. Epub 2014/03/20. doi: doi: 10.1167/iovs.13-13401 iovs.13-13401 [pii]. PMID: 24644055; PubMed Central PMCID: PMC3989087.
24. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2005; 46(7):2479-86. Epub 2005/06/28. 46/7/2479 [pii] doi: 10.1167/iovs.04-1139 PMID: 15980239.
25. Giese MJ, Rayner SA, Fardin B, Sumner HL, Rozengurt N, Mondino BJ, et al. Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2003; 44(7):3077-82. Epub 2003/06/26. PMID: 12824254.
26. Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci. 2009; 50(8):3783-93. Epub 2009/03/07. iovs.08-3051 [pii] doi: 10.1167/iovs.08-3051 PMID: 19264886; PubMed Central PMCID: PMC2880527.
27. Hu P, Pollard JD, Chan-Ling T. Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity. Am J Pathol. 2000; 156(4):1139-49. Epub 2000/04/07. S0002-9440(10)64982-6 [pii] doi: 10.1016/S0002-9440(10)64982-6 PMID: 10751337; PubMed Central PMCID: PMC1876898.
28. Singh PK, Donovan DM, Kumar A. Intravitreal Injection of the Chimeric Phage Endolysin Ply187 Protects Mice from Staphylococcus aureus Endophthalmitis. Antimicrobial Agents and Chemotherapy. 2014; 58(8):4621-9. doi: 10.1128/aac.00126-14 PMID: 24890598
29. Sadaka A, Durand ML, Gilmore MS. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: Host-microbe interactions in intraocular infection. Progress in Retinal and Eye Research. 2012; 31(4):316-31. doi: 10.1016/j.preteyeres.2012.03.004 PMID: 22521570
30. Rarey KA, Shanks RM, Romanowski EG, Mah FS, Kowalski RP. Staphylococcus aureus isolated from endophthalmitis are hospital-acquired based on Panton-Valentine leukocidin and antibiotic susceptibility testing. J Ocul Pharmacol Ther. 2012; 28(1):12-6. Epub 2011/10/22. doi: 10.1089/jop.2011.0107 PMID: 22014156; PubMed Central PMCID: PMC3272246.
31. Whiston EA, Sugi N, Kamradt MC, Sack C, Heimer SR, Engelbert M, et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 2008; 76(4):1781-90. Epub 2008/01/30. IAI.01285-07 [pii] doi: 10.1128/IAI.01285-07 PMID: 18227158; PubMed Central PMCID: PMC2292870.
32. Pietrocola G, Arciola CR, Rindi S, Di Poto A, Missineo A, Montanaro L, et al. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs. 2011; 34(9):799-810. Epub 2011/11/19. doi: doi: 10.5301/ijao.5000030 8AEDA61B-67BC-4784-8897-FD9966C45350 [pii]. PMID: 22094559.
33. Umeda A, Ueki Y, Amako K. Structure of the Staphylococcus aureus cell wall determined by the freeze-substitution method. J Bacteriol. 1987; 169(6):2482-7. Epub 1987/06/01. PMID: 3584061; PubMed Central PMCID: PMC212097.
34. Talreja D, Singh PK, Kumar A. In vivo role of TLR2 and MyD88 signaling in eliciting innate immune responses in Staphylococcal endophthalmitis. Invest Ophthalmol Vis Sci. 2015;In press.
35. Shamsuddin N, Kumar A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J Immunol. 2011; 186(12):7089-97. Epub 2011/05/24. jimmunol.1100565 [pii] doi: 10.4049/jimmunol.1100565 PMID: 21602496; PubMed Central PMCID: PMC3110513.
36. Singh P, Shiha M, Kumar A. Antibacterial responses of retinal Muller glia: production of antimicrobial peptides, oxidative burst and phagocytosis. Journal of Neuroinflammation. 2014; 11(1):33. doi: 10.1186/1742-2094-11-33
37. Otto M. Staphylococcus aureus toxins. Current Opinion in Microbiology. 2014; 17(0):32-7. doi: 10.1016/j.mib.2013.11.004
38. Kobayashi SD, DeLeo FR. Staphylococcus aureus protein A promotes immune suppression. MBio. 2013; 4(5):e00764-13. Epub 2013/10/03. doi: doi: 10.1128/mBio.00764-13e00764-13 [pii] mBio.00764-13 [pii]. PMID: 24085782; PubMed Central PMCID: PMC3791897.
39. Votintseva AA, Fung R, Miller RR, Knox K, Godwin H, Wyllie DH, et al. Prevalence of Staphylococcus aureus protein A (spa) mutants in the community and hospitals in Oxfordshire. BMC Microbiol. 2014; 14:63. Epub 2014/03/14. doi: doi: 10.1186/1471-2180-14-63 1471-2180-14-63 [pii]. PMID: 24621342; PubMed Central PMCID: PMC4007515.
40. Kumar A, Tassopoulos AM, Li Q, Yu FS. Staphylococcus aureus protein A induced inflammatory response in human corneal epithelial cells. Biochem Biophys Res Commun. 2007; 354(4):955-61. Epub 2007/02/03. doi: S0006-291X(07)00120-9 [pii] doi: 10.1016/j.bbrc.2007.01.072 PMID: 17270147; PubMed Central PMCID: PMC1864947.
41. Classen A, Kalali BN, Schnopp C, Andres C, Aguilar-Pimentel JA, Ring J, et al. TNF receptor I on human keratinocytes is a binding partner for staphylococcal protein A resulting in the activation of NF kappa B, AP-1, and downstream gene transcription. Exp Dermatol. 2011; 20(1):48-52. Epub 2010/10/20. doi: 10.1111/j.1600-0625.2010.01174.x PMID: 20955203.
42. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, et al. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med. 2004; 10(8):842-8. Epub 2004/07/13. doi: doi: 10.1038/nm1079 nm1079 [pii]. PMID: 15247912.
43. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol. 2001; 55:77-104. Epub 2001/09/07. doi: doi: 10.1146/annurev.micro.55.1.77 55/1/77 [pii]. PMID: 11544350.
44. Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA, et al. The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect Immun. 2005; 73(4):2164-74. Epub 2005/03/24. 73/4/2164 [pii] doi: 10.1128/IAI.73.4.2164-2174.2005 PMID: 15784559; PubMed Central PMCID: PMC1087460.
45. Schaefers MM, Breshears LM, Anderson MJ, Lin YC, Grill AE, Panyam J, et al. Epithelial proinflammatory response and curcumin-mediated protection from staphylococcal toxic shock syndrome toxin-1. PLoS One. 2012; 7(3):e32813. Epub 2012/03/21. doi: doi: 10.1371/journal.pone.0032813 PONE-D-11-05991 [pii]. PMID: 22431984; PubMed Central PMCID: PMC3303796.
46. Bhakdi S, Tranum-Jensen J. Alpha-toxin of Staphylococcus aureus. Microbiol Rev. 1991; 55(4):733-51. Epub 1991/12/01. PMID: 1779933; PubMed Central PMCID: PMC372845.
47. Steinbakk M, Naess-Andresen CF, Lingaas E, Dale I, Brandtzaeg P, Fagerhol MK. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet. 1990; 336(8718):763-5. Epub 1990/09/29. doi: 0140-6736(90)93237-J [pii]. PMID: 1976144.
48. Booth MC, Atkuri RV, Nanda SK, Iandolo JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995; 36(9):1828-36. Epub 1995/08/01. PMID: 7635657.
49. Kebaier C, Chamberland RR, Allen IC, Gao X, Broglie PM, Hall JD, et al. Staphylococcus aureus alpha-Hemolysin Mediates Virulence in a Murine Model of Severe Pneumonia Through Activation of the NLRP3 Inflammasome. J Infect Dis. 2012; 205(5):807-17. Epub 2012/01/27. jir846 [pii] doi: 10.1093/infdis/jir846 PMID: 22279123; PubMed Central PMCID: PMC3274379.
50. McGilligan VE, Gregory-Ksander MS, Li D, Moore JE, Hodges RR, Gilmore MS, et al. Staphylococcus aureus activates the NLRP3 inflammasome in human and rat conjunctival goblet cells. PLoS One. 2013; 8(9):e74010. Epub 2013/09/17. doi: doi: 10.1371/journal.pone.0074010 PONE-D-13-15067 [pii]. PMID: 24040145; PubMed Central PMCID: PMC3769353.
51. Gao N, Kumar A, Yu FS. MMP13 as a target for suppressing corneal ulceration caused by Pseudomonas aeruginosa infection. J Infect Dis. 2015. Epub 2015/01/16. jiv016 [pii] doi: 10.1093/infdis/jiv016 PMID: 25589337.
52. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest. 2005; 85(5):597-607. Epub 2005/02/16. 3700251 [pii] doi: 10.1038/labinvest.3700251 PMID: 15711567.
53. Sohnle PG, Hunter MJ, Hahn B, Chazin WJ. Zinc-reversible antimicrobial activity of recombinant calprotectin (migration inhibitory factor-related proteins 8 and 14). J Infect Dis. 2000; 182(4):1272-5. Epub 2000/09/09. JID000164 [pii] doi: 10.1086/315810 PMID: 10979933.
54. Ausseil J, Desmaris N, Bigou S, Attali R, Corbineau S, Vitry S, et al. Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLoS One. 2008; 3(5):e2296. Epub 2008/05/30. doi: 10.1371/journal.pone.0002296 PMID: 18509511; PubMed Central PMCID: PMC2396504.
55. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007; 81(1):28-37. Epub 2006/09/01. jlb.0306170 [pii] doi: 10.1189/jlb.0306170 PMID: 16943388.
56. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem. 1997; 272(14):9496-502. Epub 1997/04/04. PMID: 9083090.
57. Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol. 2005; 78(1):1-8. Epub 2005/03/01. jlb.1104648 [pii] doi: 10.1189/jlb.1104648 PMID: 15734795.
58. Claudio L, Martiney JA, Brosnan CF. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab Invest. 1994; 70(6):850-61. Epub 1994/06/01. PMID: 8015289.
59. Wiskur BJ, Robinson ML, Farrand AJ, Novosad BD, Callegan MC. Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2008; 49(4):1480-7. Epub 2008/04/04. 49/4/1480 [pii] doi: 10.1167/iovs.07-1303 PMID: 18385066; PubMed Central PMCID: PMC2531288.